CS logo
small CS logo
Illinois Retina Associates

Joliet, Illinois, United States
Ophthalmologist in Joliet, Illinois
300 Barney Dr Suite D, Joliet, IL 60435

About Illinois Retina Associates


"Illinois Retina Associates is committed to excellence. We are one of the leading retina practices in the US devoted to diagnosing & treating diseases of the retina, macula & vitreous. Our retina specialists also have more than a centry of experience in treating macular degeneration, diabetic retinopathy, vascular retinal detachments, flashes & floaters, uveitis, ocular oncology & more. We use state of the art testing & treatments including retinal laser treatment, fluorescein angiography, optical coherence tomography, ultrasound & intravitreal injections. We participate in national & international clinical trials & research studies and participate in a 2-year fellowship program in conjunction with Rush University Medical Center."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Jaeb Center for Health Research
5
Hoffmann-La Roche
4
Aldeyra Therapeutics, Inc.
1
Genentech, Inc.
1
Illinois Retina Associates
1
Johns Hopkins University
1
Merck Sharp & Dohme LLC
1
Neurotech Pharmaceuticals
1
University of Pennsylvania
1
Total Rows: 9

Clinical Trials at Illinois Retina Associates


During the past decade, Illinois Retina Associates conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 4 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years110000222211000011000011Started TrialsCompleted Trails2015201620172018201920200123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study of Denufosol (INS37217) in Subjects With Rhegmatogenous Retinal Detachment
2004-06-01
2006-04-01
Terminated
23
A Phase 2 Evaluation of Anti-VEGF Therapy for Diabetic Macular Edema: Bevacizumab (Avastin)
2006-06-01
2008-02-01
Completed
121
Intravitreal Triamcinolone Acetonide Versus Laser for Diabetic Macular Edema
2004-07-01
2008-10-01
Completed
840
Laser-Ranibizumab-Triamcinolone for Diabetic Macular Edema
2007-03-01
2014-02-01
Completed
691
Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy
2007-03-01
2010-07-01
Completed
333
Comparison of Age-related Macular Degeneration Treatments Trials: Lucentis-Avastin Trial
2008-02-01
2015-04-01
Completed
1,208
Patient Assessment of Topical Anesthetic Effectiveness for Intravitreal Injections
2009-10-01
2009-12-01
Completed
120
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
2010-02-01
2013-03-01
Completed
152

Rows per page:

1–16 of 16

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Illinois Retina Associates" #1 sponsor was "Jaeb Center for Health Research" with 5 trials, followed by "Hoffmann-La Roche" with 4 trials sponsored, "Aldeyra Therapeutics, Inc." with 1 trials sponsored, "Genentech, Inc." with 1 trials sponsored and "Illinois Retina Associates" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Illinois Retina Associates" #1 collaborator was "National Eye Institute (NEI)" with 6 trials as a collaborator, "Allergan" with 3 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator, "Juvenile Diabetes Research Foundation" with 1 trials as a collaborator and "National Institutes of Health (NIH)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.
Created with Highcharts 11.1.0Top Leading SponsorsJaeb Center for HealthResearch: 5Jaeb Center for HealthResearch: 5Hoffmann-La Roche: 4Hoffmann-La Roche: 4Aldeyra Therapeutics, Inc.: 1Aldeyra Therapeutics, Inc.: 1Genentech, Inc.: 1Genentech, Inc.: 1Illinois Retina Associates: 1Illinois Retina Associates: 1Johns Hopkins University: 1Johns Hopkins University: 1Merck Sharp & Dohme LLC: 1Merck Sharp & Dohme LLC: 1Neurotech Pharmaceuticals: 1Neurotech Pharmaceuticals: 1University of Pennsylvania: 1University of Pennsylvania: 1

Created with Highcharts 11.1.0Top CollaboratorsNational Eye Institute (NEI): 6National Eye Institute (NEI): 6Allergan: 3Allergan: 3Genentech, Inc.: 2Genentech, Inc.: 2Juvenile DiabetesResearch Foundation: 1Juvenile DiabetesResearch Foundation: 1National Institutes ofHealth (NIH): 1National Institutes ofHealth (NIH): 1Regeneron Pharmaceuticals: 1Regeneron Pharmaceuticals: 1

Clinical Trials Conditions at Illinois Retina Associates


According to Clinical.Site data, the most researched conditions in "Illinois Retina Associates" are "Diabetic Macular Edema" (6 trials), "Diabetic Retinopathy" (3 trials), "Macular Degeneration" (2 trials), "Neovascular Age-Related Macular Degeneration" (2 trials) and "Age Related Macular Degeneration" (1 trials). Many other conditions were trialed in "Illinois Retina Associates" in a lesser frequency.

Clinical Trials Intervention Types at Illinois Retina Associates


Most popular intervention types in "Illinois Retina Associates" are "Drug" (16 trials), "Procedure" (4 trials), "Behavioral" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Ranibizumab" (3 trials), "Intravitreal Ranibizumab 0.5 mg Injection" (2 trials), "PDS Implant Pre-Filled with 100 mg/mL Ranibizumab" (2 trials), "ranibizumab" (2 trials) and "1mg triamcinolone acetonide" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Illinois Retina Associates


The vast majority of trials in "Illinois Retina Associates" are 16 trials for "All" genders.

Clinical Trials Status at Illinois Retina Associates


Currently, there are NaN active trials in "Illinois Retina Associates". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Illinois Retina Associates, undefined suspended trials, and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Illinois Retina Associates, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 11Phase 3: 11Phase 2: 5Phase 2: 5Phase 1: 1Phase 1: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 11Completed: 11Active, not recruiting: 2Active, not recruiting: 2Terminated: 2Terminated: 2Recruiting: 1Recruiting: 1